Welcome to our dedicated page for Catalyst Crew Technologies SEC filings (Ticker: CCTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Catalyst Crew Technologies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Catalyst Crew Technologies's regulatory disclosures and financial reporting.
Catalyst Crew Technologies Corp. is a development-stage company building facial recognition software and reported no revenue for 2025 or 2024. For the year ended December 31, 2025, it recorded a net loss of $207,485, compared with a loss of $3,261,038 in 2024.
The balance sheet is extremely weak: as of December 31, 2025 the company reported no assets or cash and total liabilities of $630,860, resulting in a stockholders’ deficit of the same amount. The auditor issued a going concern paragraph, citing recurring losses, a large accumulated deficit of $29,600,786, and dependence on external financing.
The business has not commercialized its facial recognition technology and remains focused on research and development, funded by equity sales and notes payable. In February 2026, Dr. Kevin Rodan Levy acquired and was issued shares to reach 40,000,000 shares, or about 71.1% ownership, triggering a change in control and new leadership.
Catalyst Crew Technologies Corp. entered an Asset Purchase Agreement on February 17, 2026 with its CEO, Kevin Rodan Levy, to acquire assets for an artificial intelligence-enabled healthcare analytics platform, including CardioAI, PulmoAI, and NeuroAI intellectual property registered in Venezuela.
On March 23, 2026, the company acquired 100% of the shares of Inversiones Long 33, C.A., which became a wholly-owned Venezuelan subsidiary intended as its local operating entity within a broader Latin American strategy. On April 7, 2026, certain previously acquired intellectual property was assigned to this subsidiary as an internal reorganization step with no additional consideration.
The company also highlighted multiple press releases between March 23 and April 13, 2026 describing its operating structure, intellectual property assignments, and the introduction of its CardioAI, PulmoAI, and NeuroAI platforms.
Catalyst Crew Technologies Corp. appointed Carlos Peña as its new Chief Financial Officer, effective March 31, 2026. Peña, age 38, brings over ten years of experience in accounting, financial management, and audit support across several Venezuelan and international businesses.
The company reports no family relationships or related party transactions involving Peña, and notes that his appointment was not made under any prior arrangements. As of this report, there is no formal employment agreement in place and his compensation package has not yet been finalized.
Catalyst Crew Technologies Corp. filed a Form 12b-25 notification stating it cannot timely file its Annual Report on Form 10-K for the period ended December 31, 2025 due to delays in compiling and reviewing certain information required to finalize the financial statements. The company expects to file within the 15 calendar day extension period permitted under Rule 12b-25. The notification is signed by Kevin Rodan Levy, Chief Executive Officer, and dated March 31, 2026.
Catalyst Crew Technologies Corp. completed a transformational deal and change in control, shifting from an inactive shell to a development-stage digital health and artificial intelligence healthcare analytics company. The company acquired AI-enabled analytics and telehealth-related assets from its new CEO, Dr. Kevin Rodan Levy, in exchange for 12,000,000 restricted common shares.
Dr. Levy also purchased 28,000,000 existing shares for $10,000 in cash, giving him beneficial ownership of about 40,000,000 shares, or roughly 71.1% of the 56,296,895 common shares outstanding. All prior directors and officers resigned, and Dr. Levy became sole director and officer. The business remains pre-revenue, requires substantial additional capital, holds key patents only in Venezuela, and faces significant regulatory, competitive, and going concern risks as it tries to build and commercialize its AI and telehealth platforms, initially targeting Latin American markets.
Catalyst Crew Technologies Corp. (CCTC) filed its Q3 2025 report, showing no revenue and a smaller quarterly net loss as the company remains pre‑revenue. Net loss was $36,302 for the quarter ended September 30, 2025, improving from $43,481 a year ago. For the nine months, net loss was $89,939 versus $2,343,608 in 2024, primarily due to lower stock‑based compensation.
The balance sheet reflects constrained liquidity: cash $0, current liabilities $663,514, and a working capital deficit of $663,514. Debt includes promissory notes of $264,414, related‑party notes of $88,042, and convertible notes of $34,591. Interest expense totaled $26,183 for the nine months.
Management disclosed a going concern uncertainty due to continuing losses and lack of committed financing. Internal controls over financial reporting were deemed not effective with material weaknesses tied to limited resources and segregation of duties. Common shares outstanding were 29,276,895 as of November 14, 2025.